Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIFT: FMT in HIV
NCT03163784Phase 2Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2018
- Primary completion
- Jun 2020
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation capsules in human immunodeficiency virus infection (HIV), sponsored by Massachusetts General Hospital. Planned start Jun 2018; status: withdrawn.
02
Drugs
Fecal Microbiota Transplantation capsules
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03163784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03163784.